Skip to main content
A quant shop's stocks and options workflow, simplified into one desk.

Why it exists

Built for traders who take process seriously.

PredictDesk exists because serious traders rarely lack inputs. They lack continuity. The thesis lives in one place, the scan in another, chart notes somewhere else, and the backtest in a separate tool. PredictDesk is built to bring that research process back into one disciplined workflow.

Product philosophy

Make the workflow stronger, not louder.

The goal is not to drown traders in more noise, more picks, or more feature theater. The goal is to make the research process more inspectable, more testable, and more repeatable.

  • Bring scattered research back into one coherent desk workflow.
  • Make assumptions, evidence, and tradeoffs easier to inspect.
  • Keep the broker boundary explicit instead of blurring it.

Who this is built for

Serious trader means high agency, not hype tolerance.

PredictDesk is built for traders who already know there is no substitute for judgment. They want better structure around decisions, not someone else pretending to make the decision for them.

  • People who already use charts, screeners, notes, backtests, and broker tools.
  • Traders who want more control and more visibility, not easier fantasies.
  • Users who care about process quality before capital is at risk.

Why invite-only

The invite-only posture is part of the trust story.

A serious product should not overstate access, readiness, or what a waitlist means. PredictDesk uses the public site to explain the workflow clearly before broader access expands.

  • Waitlist signup records interest and updates.
  • It does not guarantee approval, product access, or billing.
  • The public story stays stronger when access claims stay exact.

Boundary

What PredictDesk will not pretend to be

PredictDesk is not a broker, investment adviser, custodian, execution venue, signal seller, or guaranteed-performance product. Waitlist signup records interest only and does not promise approval, access, billing, or availability.

Not a broker. Not investment advice. Backtests and scenario results are hypothetical. Options involve significant risk. Waitlist signup does not create approval or access.